Filana CEO buys 306,813 shares

Posted by Donald Scott on Oct 1st, 2026

What happened

Filana Therapeutics, Inc. (NASDAQ: FLNA) said Richard Barry bought 306,813 shares of common stock from 2026-09-29 to 2026-09-30.

Barry is the company's President & CEO and a director. The filing shows 206,813 shares bought on 2026-09-29 at a weighted average price of $0.90. It shows 100,000 shares bought on 2026-09-30 at $0.92. The purchases were made in multiple open-market transactions. The footnotes say the first-day trades ranged from $0.86 to $0.94. They say the second-day trades ranged from $0.91 to $0.93.

The report puts the total at about $278,132 and says Barry held 1,337,964 shares afterward, indirectly by trust.

Key numbers

Metric	Latest	Source
Shares purchased	306,813 shares	SEC Form 4
Purchase price range	$0.90 to $0.92 per share	SEC Form 4
Total value	about $278,132	SEC Form 4
Shares held afterward	1,337,964 shares	SEC Form 4

Why it matters

OptimistFi's case is that Filana is a clinical-stage biotech option whose value depends on turning its remaining development work into credible external validation before cash runway and dilution risk overwhelm shareholders. Barry's buying strengthens that case modestly by adding insider alignment.

OptimistFi's calculation puts the purchase at about 29.8% of his prior holding. The filing also shows the stake was built in two days, with 206,813 shares on 2026-09-29 and 100,000 shares on 2026-09-30.

The first-day footnote says the shares were bought in multiple open-market transactions at prices from $0.86 to $0.94 per share, while the second-day footnote gives a $0.91 to $0.93 range. Barry's post-trade ownership is indirect by trust, which means the filing records control through that structure rather than direct share ownership.

This is still an open-market insider purchase, so it can signal confidence. It does not itself prove clinical progress or financing improvement.

Browse: stock research on every company OptimistFi covers

What's next

The filing's latest transaction date is 2026-09-30, and it was signed and filed on 2026-10-01. That gives investors a fresh baseline for Barry's 1,337,964-share holding.

The Form 4 itself is the dated record investors can compare against any future insider report from here. Later Form 4s showing more buying would strengthen the case, while a smaller stake would weaken it.